Technetium-99m Methylene Diphosphonate (99mtcMdp): A Comprehensive Review of Its Chemistry, Clinical Utility, and Emerging Applications
Article Sidebar
Main Article Content
Abstract
Methylene diphosphonate (⁹⁹ᵐTc-MDP) is a boneimaging radiopharmaceutical widely used in nuclear medicine for decades. This review provides a detailed introduction to ⁹⁹ᵐTcMDP bone imaging, including preparation, chemical properties, radiolabeling techniques, quality control, clinical applications, and recent developments. This article emphasises MDP kit preparation, the basic principles of radiopharmaceutical labelling, and the importance of technetium-99m as a diagnostic radionuclide. Over the years, researchers have also emphasised radiolabeling efficiency, radiochemical purity, and the stability of radiopharmaceutical preparations to ensure safe, effective use. This review highlights the clinical role of ⁹⁹ᵐTc-MDP in detecting and evaluating different skeletal lesions (i.e., fractures, bone metastases, metabolic bone diseases). It also describes the current state of bone imaging and the enduring role of ⁹⁹ᵐTc-MDP as a diagnostic tool. The discussion also covers new applications, technological advances, radiation exposure, and patient safety. It also discusses future perspectives in nuclear pharmacy, including the development of new radiopharmaceuticals and improved imaging strategies. This review compiles available data and provides insights for nuclear medicine professionals, radiologists, and researchers on current applications, technical aspects, and prospects for ⁹⁹ᵐTc-MDP in imaging skeletal phenomena.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
S. Salih, A. Alkatheeri, W. Alomaim, and A. Elliyanti, “Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges,” Molecules 2022, Vol. 27, Page 5231, vol. 27, no. 16, p. 5231, Aug. 2022,
DOI: 10.3390/MOLECULES27165231
H. A. Jacene, J. L. Urbain, J. S. Lewis, H. Nadel, J. D. Bolin, and C. S. Cutler, “Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for Expertise,” Journal of Nuclear Medicine, vol. 66, no. 12, pp. 1871–1879, Dec. 2025,
DOI: 10.2967/JNUMED.125.271028
S. Zhang et al., “Radionuclide-labeled biomaterials: A novel strategy for tumor-targeted therapy,” mdpi.com, vol. 21, no. 4, pp. 508–524, Jun. 2024, DOI: 10.2174/0115733947303281240522131837
M. F. Nawar and A. Türler, “New strategies for a sustainable 99mTc supply to meet increasing medical demands: Promising solutions for current problems,” Front. Chem., vol. 10, p. 926258, Jul. 2022, DOI: 10.3389/FCHEM.2022.926258/FULL
N. Ahmed and M. Zia, “Diagnostic modalities and radiopharmaceuticals with particular importance of technetium-99m (99mTc),” Chinese Journal of Academic Radiology 2023 6:4, vol. 6, no. 4, pp. 143–159, Nov. 2023, DOI: 10.1007/S42058-023-00128-7
S. Vallabhajosula, R. P. Killeen, and J. R. Osborne, “Altered Biodistribution of Radiopharmaceuticals: Role of Radiochemical/Pharmaceutical Purity, Physiological, and Pharmacologic Factors,” Semin. Nucl. Med., vol. 40, no. 4, pp. 220–241, Jul. 2010, DOI: 10.1053/J.SEMNUCLMED.2010.02.004
R. Lange, N. Schreuder, and H. Hendrikse, “Radiopharmaceuticals,” Practical Pharmaceutics: An International Guideline for the Preparation, Care and Use of Medicinal Products, Second Edition, pp. 531–550, Mar. 2026, DOI: 10.1007/978-3-031-20298-8_23
D. Ilem-Ozdemir, E. Atlihan Gundogdu, M. Ekinci, E. Ozgenc, and M. Asikoglu, “Nuclear medicine and radiopharmaceuticals for molecular diagnosis,” Biomedical Applications of Nanoparticles, pp. 457–490, Jan. 2019, DOI: 10.1016/B978-0-12-816506-5.00017-6
P. Pitriani, Y. W. Wardhana, and A. Y. Chaerunisaa, “Improving Stability and Absorption of Minerals in Pharmaceutical Formulations: A Review of Emerging Strategies,” Chempublish Journal, vol. 9, no. 2, pp. 196–220, Jan. 2025, DOI: 10.22437/CHP.V9I2.46931
Z. Cai, X. Lin, Y. Zhuang, W. Miao, and Y. Xie, “Augmentation of bone formation by sympathectomy in rats as evaluated by [99mTc]Tc-MDP,” Front. Endocrinol. (Lausanne). vol. 16, p. 1580230, Jul. 2025, DOI: 10.3389/FENDO.2025.1580230/TEXT
“Mechanisms of Fixation of Bone Imaging Radiopharmaceuticals,” pp. 115–144, Nov. 2017, DOI: 10.1201/9780203710210-5
A. K. Thokchom, R. Kumar, S. Bharati, and Vasumathi, “Quality Assessment of Tc-99m Methylene Diphosphonate (MDP) Radiopharmaceutical Prepared Using Different Cold Kit Fractionation Methods,” Indian J. Nucl. Med., vol. 37, no. 1, p. 7, Jan. 2022,
DOI: 10.4103/IJNM.IJNM_115_21
G. B. Saha, “Radionuclide Generators,” Fundamentals of Nuclear Pharmacy, pp. 77–92, 2018, DOI: 10.1007/978-3-319-57580-3_5
D. Papagiannopoulou, “Technetium-99m radiochemistry for pharmaceutical applications,” J. Labelled Comp. Radiopharm., vol. 60, no. 11, pp. 502–520, Sep. 2017, JOURNAL: JOURNAL:10991344A; CTYPE:STRING:JOURNAL. DOI: 10.1002 /JLCR.3531
F. Jayanto Kelutur and H. Abdul Holik, “Use of 99m Tc in The Field of Radiofarmation: A Review,” Biomedical Journal of Indonesia, vol. 7, p. 2021, DOI: 10.32539/BJI.v7i1.241
A. Duatti, “Review on 99mTc radiopharmaceuticals with emphasis on new advancements,” Nucl. Med. Biol., vol. 92, pp. 202–216, Jan. 2021, DOI: 10.1016/j.nucmedbio.2020.05.005
P. Martini, M. Pasquali, A. Boschi, L. Uccelli, M. Giganti, and A. Duatti, “Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands,” Molecules 2018, Vol. 23, Page 2039, vol. 23, no. 8, p. 2039, Aug. 2018, DOI: 10.3390/MOLECULES23082039
A. Duatti, “Fundamentals of technetium-99m radiopharmaceutical chemistry,” Basic Sciences of Nuclear Medicine: Second Edition, pp. 73–101, May 2021, DOI: 10.1007/978-3-030-65245-6_4/SAVE-RESEARCH
P. H. Cox and C. M. King, “Radiopharmacy and radiopharmacology yearbook,” 2021, Accessed: Oct. 19, 2026. [Online]. Available: https://books.google.com/books/about/Radiopharmacy_and_Radiopharmacology_Year.html?id=2d1FEAAAQBAJ
D. A. Atwood, “Radionuclides in the Environment,” p. 532, 2013.
G. M. Currie, J. M. Wheat, R. Davidson, and H. Kiat, “Radionuclide production,” J. Med. Radiat. Sci., vol. 58, no. 3, pp. 46–52, Sep. 2011, TB00155.X; PAGEGROUP:STRING:PUBLICATION. DOI: 10.1002/J.2051-3909.2011
S. K. Rizvi, S. Tariq, F. Gilani, A. Javed, and I. Rafique, “In-house production of [99mTc][Tc-HYNIC-TATE] cold kit for the diagnosis of neuroendocrine tumors in Pakistan: pre-clinical and clinical evaluation of indigenously manufactured single and dual vial kit formulation,” Journal of Radioanalytical and Nuclear Chemistry 2024 334:1, vol. 334, no. 1, pp. 141–152, Sep. 2024, DOI: 10.1007/S10967-024-09726-W
N. Bhatia, R. Vatsa, V. K. Dhingra, D. K. Dhawan, and V. D. Chadha, “Evaluation of Tetrofosmin Cold Kit Fractionation Using Alternative New Method of Quality Control for Testing Radiochemical Purity,” World J. Nucl. Med., vol. 21, no. 04, pp. 314–319, Dec. 2022,
DOI: 10.1055/S-0042-1757381
A. Boschi, L. Uccelli, and P. Martini, “A Picture of Modern Tc-99m Radiopharmaceuticals: Production, Chemistry, and Applications in Molecular Imaging,” Applied Sciences 2019, Vol. 9, Page 2526, vol. 9, no. 12, p. 2526, Jun. 2019, DOI: 10.3390/APP9122526
L. Giovanella, A. Avram, and J. Clerc, “Molecular Imaging for Thyrotoxicosis and Thyroid Nodules,” Journal of Nuclear Medicine, vol. 62, no. Supplement 2, pp. 20S-25S, Jul. 2021, DOI: 10.2967/JNUMED.120.246017
R. Lim et al., “Review of the Clinical and Technical Aspects of 99mTc-Dimercaptosuccinic Acid Renal Imaging: The Comeback ‘Kit,’” J. Nucl. Med. Technol., vol. 52, no. 3, pp. 199–204, Sep. 2024, DOI: 10.2967/JNMT.123.267185
C. S. Low and N. Rao, “Imaging of Gastrointestinal Bleeding: An Update,” Semin. Nucl. Med., vol. 53, no. 6, pp. 766–776, Nov. 2023, DOI: 10.1053/J.SEMNUCLMED.2023.06.002
E. Karabulut, F. A. Celik, and M. Yilmaz, “The advantages of transition metal chelated by methylene diphosphonate and its doped-on hydroxyapatite crystals: High h-production with low metal usage, electro-catalysis possibility and reuse capability,” Surfaces and Interfaces, vol. 78, p. 108055, Dec. 2025, DOI: 10.1016/J.SURFIN.2025.108055
A. Amir, A. H. Sayer, A. Ezra, and B. Fischer, “Methylenediphosphonotetrathioate: Synthesis, Characterization, and Chemical Properties,” Inorg. Chem., vol. 52, no. 6, pp. 3133–3140, Mar. 2013, DOI: 10.1021/IC3026057
X. Hou, Y. He, G. Liu, S. Chen, and H. Shi, “SPECT/CT imaging: quantifying 99mTc-MDP concentration in the spine and pelvis,” Ann. Nucl. Med., vol. 38, no. 12, pp. 933–942, Dec. 2024, DOI: 10.1007/S12149-024-01967-9
W. Sun et al., “Observation of the Short-term Efficacy of Technetium-99 Conjugated with Methylene Diphosphonate Combined Therapy in the Treatment of Postmenopausal Osteoporosis,” Comb. Chem. High Throughput Screen., vol. 27, no. 13, pp. 1930–1937, Feb. 2024,
DOI: 10.2174/0113862073266467231228124942/CITE/REFWORKS
S. Komal, S. Nadeem, Z. Faheem, A. R.-… Isotopes, and undefined 2020, “Localization mechanisms of radiopharmaceuticals,” intechopen.comS Komal, S Nadeem, Z Faheem, A Raza, K Sarwer, H Umer, S Roohi, SAR Naqvi Medical Isotopes, 2020•intechopen.com, Accessed: Sep. 16, 2025. [Online]. DOI: 10.5772/intechopen.94099
L. Nie, Z. Sun, F. Shan, C. Li, X. Ding, and C. Shen, “An artificial intelligence framework for the diagnosis of prosthetic joint infection based on 99mTc-MDP dynamic bone scintigraphy,” European Radiology 2023 33:10, vol. 33, no. 10, pp. 6794–6803, Apr. 2023,
DOI: 10.1007/S00330-023-09687-W
P. Subramanyam and S. S. Palaniswamy, “Diagnostic Performance of Integrated 18F FDG PETMR in the Diagnosis of Recurrent Foot Infection—Comparison with 18F FDG PETCT and Conventional 99mTc MDP Bone Scan,” World J. Nucl. Med., vol. 24, no. 02, pp. 107–117, Jun. 2025, DOI: 10.1055/S-0044-1800836
K. Vermeulen, M. Vandamme, G. Bormans, and F. Cleeren, “Design and Challenges of Radiopharmaceuticals,” Semin. Nucl. Med., vol. 49, no. 5, pp. 339–356, Sep. 2019, DOI: 10.1053/j.semnuclmed.2019.07.001
D. Psimadas, P. Bouziotis, P. Georgoulias, V. Valotassiou, T. Tsotakos, and G. Loudos, “Radiolabeling approaches of nanoparticles with 99mTc,” Contrast Media Mol. Imaging, vol. 8, no. 4, pp. 333–339, Jul. 2013, DOI: 10.1002/CMMI.1530
C. Shaun Loveless and S. E. Lapi, “Production of therapeutic radionuclides,” Handbook of Radiopharmaceuticals: Methodology and Applications: Second Edition, pp. 89–105, Jan. 2021, CH5; CTYPE. DOI: 10.1002/9781119500575
M. S. Islam et al., “Routine Radiochemical Quality Control of 99mTc eluate and 99mTc-Labeled Radiopharmaceuticals,” Bangladesh Journal of Nuclear Medicine, vol. 26, no. 2, pp. 193–197, Jun. 2023, DOI: 10.3329/BJNM.V26I2.71493
H. Gao et al., “Comparison of diagnostic efficacy between 99mTc-methylene diphosphate SPECT/CT and MRI for bone and joint infections: a multicenter retrospective analysis,” Front. Endocrinol. (Lausanne). vol. 15, p. 1359655, Feb. 2024,
DOI: 10.3389/FENDO.2024.1359655/TEXT
K. Peepre, A. N. Tiwari, and J. P. Sharma, “Clinical Significance of 99m Tc-MDP Imaging & Molecular Biology in the Diagnosis of Bone Metastases,” IOSR J. Pharm., vol. 4, no. 2, pp. 50–55, 2014, Accessed: Oct. 19, 2026. [Online]. Available: http://www.iosrphr.org/,
DOI: 10.1016/j.ijgc.2025.102282
E. J. Miller et al., “Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement,” Journal of Nuclear Cardiology, vol. 29, no. 5, pp. 2748–2760, Oct. 2022, DOI: 10.1007/s12350-022-03059-5
M. Bermo, S. Behnia, J. Fair, R. S. Miyaoka, and S. Elojeimy, “Review of Extraskeletal Activity on Tc-99m Methylene Diphosphonate Bone Scintigraphy and Value of Cross-Sectional and SPECT-CT Imaging Correlation,” Curr. Probl. Diagn. Radiol., vol. 47, no. 5, pp. 324–332, Sep. 2018, DOI: 10.1067/J.CPRADIOL.2017.07.009
M. Maharaj, S. Sirriram, N. Govender, T. Govender, B. D. Bhana, and N. Korowlay, “Extraosseous 99mTc-MDP Uptake Guiding Intraoperative Sampling in Severe Inflammatory Myopathy: A Case Report and Literature Review,” Diagnostics, vol. 16, no. 11, p. 1684, Jun. 2026, DOI: 10.3390/DIAGNOSTICS16111684
S. Usmani, A. Jain, K. Al Riyami, Z. Niaz, S. Kheruka, and V. V. Jayakrishnan, “Unusual Soft Tissue Uptake of Tc-99m MDP in Radiation-induced Sarcoma: Diagnostic Conundrum.,” Mol. Imaging Radionucl. Ther., vol. 33, no. 2, pp. 106–108, Jun. 2024,
DOI: 10.4274/MIRT.GALENOS.2023.58224